Tirzepatide recently got approval for treating moderate-to-severe sleep apnea
According to MedlinePlus semaglutide injection information, nausea, vomiting, diarrhea, stomach pain, constipation, heartburn, and burping are listed among possible side effects
Not affiliated: PlexusDx has no commercial relationship with Ivim Health or any other brand named here
Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome
Tirzepatide (Mounjaro, Zepbound) Strengths: Highest efficacy for both glucose control and weight loss Dual mechanism (GLP-1 + GIP) may provide unique benefits Once-weekly dosing Generally well-tolerated Considerations: Higher cost than semaglutide Less long-term safety data (newer medication) Cardiovascular outcome trial not yet complete (though expected to be positive) Best for: Patients prioritizing maximum weight loss
References Alkabbani, W., Zongo, A., Minhas-Sandhu, J